Collectively, our findings reveal a previously unrecognized hsa_circ_0058495-IGF2BP2-MEKK1 axis, which drives PDAC progression and fosters a tumor-supportive microenvironment, highlighting hsa_circ_0058495 as a potential therapeutic target. The gene discussed is IGF2BP2; the disease is neoplasm.